REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • December 19th, 2017 • Riot Blockchain, Inc. • In vitro & in vivo diagnostic substances
Contract Type FiledDecember 19th, 2017 Company IndustryTHIS REGISTRATION RIGHTS AGREEMENT (this "Agreement") is made as of _________ 2017, among Riot Blockchain, Inc., a Nevada (the "Company"), the investor signatory hereto (the "Investor"). Capitalized terms not otherwise defined herein shall have the meaning ascribed to them in the Purchase Agreement (as defined below).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • December 19th, 2017 • Riot Blockchain, Inc. • In vitro & in vivo diagnostic substances • New York
Contract Type FiledDecember 19th, 2017 Company Industry JurisdictionThis Securities Purchase Agreement (this "Agreement") is dated as of December__, 2017, between Riot Blockchain, Inc., a Nevada corporation (the "Company"), and each purchaser identified on the signature pages hereto (each, including its successors and permitted assigns, a "Purchaser" and collectively, the "Purchasers").
FORM OF COMMON STOCK PURCHASE WARRANTRiot Blockchain, Inc. • December 19th, 2017 • In vitro & in vivo diagnostic substances
Company FiledDecember 19th, 2017 IndustryTHIS COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received, [______] or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the six month anniversary of the Initial Issuance Date (the "Initial Exercise Date") and on or prior to the close of business on the thirty six (36) month anniversary of the Initial Exercise Date (the "Termination Date") but not thereafter, to subscribe for and purchase from RIOT BLOCKCHAIN, INC., a Nevada corporation (the "Company"), up to [____] shares (as subject to adjustment hereunder, the "Warrant Shares") of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).